Durvalumab

ATC L01FF03 · 10 markets · 24 records

Durvalumab 10 markets · 24 records Forms

ES 6 records · 1 strengths

50 mg/1 mLinjectionIMFINZI

AU 5 records · 5 strengths

500 mg/10 mLinjectionIMFINZI also in US·GB
120 mg/2.4 mLinjectionIMFINZI also in US·GB
500 mginjectionIMFINZI durvalumab (rch) 120 mg concentrated injection vial unknown
120 mginjectionIMFINZI durvalumab (rch) 120 mg concentrated injection vial unknown

Records without a stated strength · 1 IMFINZI

US 4 records · 2 strengths

500 mg/10 mLinjectionIMFINZI+1__no_trade__ also in AU·GB
120 mg/2.4 mLinjectionIMFINZI+1__no_trade__ also in AU·GB

GB 2 records · 2 strengths

500 mg/10 mLinjectionImfinzi 500mg/10ml concentrate for solution for infusion vials also in AU·US
120 mg/2.4 mLinjectionImfinzi 500mg/10ml concentrate for solution for infusion vials also in AU·US

HK 2 records · 1 strengths

Records without a stated strength · 1 IMFINZI CONCENTRATE FOR SOLUTION FOR INFUSION 120MG/2.4ML

CA 1 records · 1 strengths

50 mgliquidIMFINZI

SG 1 records · 1 strengths

50 mg/mLinjectionIMFINZI CONCENTRATE FOR SOLUTION FOR INFUSION 50 MG/ML

TW 1 records · 1 strengths

50 mginjectionIMFINZI Injection 50 mg/ml+1抑癌寧注射劑

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 IMFINZI

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.